Due to the importance of GLP-1 signaling on cognitive function [9] and the relationship between AD and T2D [10], GLP-1 analogs, and LRGT specifically, may provide a relevant venue to ameliorate AD pathology [11]. This evidence concerns the gene GLP1R and Alzheimer disease.